Logo image of AMSF

AMERISAFE INC (AMSF) Stock Fundamental Analysis

NASDAQ:AMSF - Nasdaq - US03071H1005 - Common Stock - Currency: USD

44.82  +0.66 (+1.49%)

After market: 44.82 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMSF. AMSF was compared to 145 industry peers in the Insurance industry. Both the profitability and the financial health of AMSF get a neutral evaluation. Nothing too spectacular is happening here. AMSF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AMSF was profitable.
In the past year AMSF had a positive cash flow from operations.
In the past 5 years AMSF has always been profitable.
Each year in the past 5 years AMSF had a positive operating cash flow.
AMSF Yearly Net Income VS EBIT VS OCF VS FCFAMSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

AMSF's Return On Assets of 4.10% is amongst the best of the industry. AMSF outperforms 83.45% of its industry peers.
AMSF's Return On Equity of 18.20% is amongst the best of the industry. AMSF outperforms 86.21% of its industry peers.
The Return On Invested Capital of AMSF (4.17%) is better than 78.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMSF is in line with the industry average of 4.07%.
Industry RankSector Rank
ROA 4.1%
ROE 18.2%
ROIC 4.17%
ROA(3y)4.74%
ROA(5y)4.96%
ROE(3y)20.1%
ROE(5y)19.3%
ROIC(3y)4.78%
ROIC(5y)4.81%
AMSF Yearly ROA, ROE, ROICAMSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 15.84%, AMSF belongs to the top of the industry, outperforming 84.14% of the companies in the same industry.
AMSF's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 19.34%, AMSF is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
AMSF's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 19.34%
PM (TTM) 15.84%
GM N/A
OM growth 3Y-3.47%
OM growth 5Y-8.09%
PM growth 3Y-5.13%
PM growth 5Y-6.1%
GM growth 3YN/A
GM growth 5YN/A
AMSF Yearly Profit, Operating, Gross MarginsAMSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMSF is destroying value.
AMSF has less shares outstanding than it did 1 year ago.
The number of shares outstanding for AMSF has been reduced compared to 5 years ago.
The debt/assets ratio for AMSF has been reduced compared to a year ago.
AMSF Yearly Shares OutstandingAMSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AMSF Yearly Total Debt VS Total AssetsAMSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

There is no outstanding debt for AMSF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.46
WACC9.07%
AMSF Yearly LT Debt VS Equity VS FCFAMSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AMSF Yearly Current Assets VS Current LiabilitesAMSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2

3. Growth

3.1 Past

The earnings per share for AMSF have decreased strongly by -12.27% in the last year.
AMSF shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.34% yearly.
The Revenue has decreased by -1.50% in the past year.
AMSF shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.91% yearly.
EPS 1Y (TTM)-12.27%
EPS 3Y-3.68%
EPS 5Y-11.34%
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y-0.45%
Revenue growth 5Y-3.91%
Sales Q2Q%-9.81%

3.2 Future

Based on estimates for the next years, AMSF will show a decrease in Earnings Per Share. The EPS will decrease by -5.63% on average per year.
Based on estimates for the next years, AMSF will show a small growth in Revenue. The Revenue will grow by 1.91% on average per year.
EPS Next Y-7.94%
EPS Next 2Y-5.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.6%
Revenue Next 2Y1.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AMSF Yearly Revenue VS EstimatesAMSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
AMSF Yearly EPS VS EstimatesAMSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.44 indicates a rather expensive valuation of AMSF.
Compared to the rest of the industry, the Price/Earnings ratio of AMSF indicates a slightly more expensive valuation: AMSF is more expensive than 63.45% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.52, AMSF is valued a bit cheaper.
With a Price/Forward Earnings ratio of 19.97, AMSF is valued on the expensive side.
Based on the Price/Forward Earnings ratio, AMSF is valued a bit more expensive than the industry average as 70.34% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 35.58. AMSF is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.44
Fwd PE 19.97
AMSF Price Earnings VS Forward Price EarningsAMSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AMSF.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMSF indicates a slightly more expensive valuation: AMSF is more expensive than 76.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 57.71
EV/EBITDA 13.52
AMSF Per share dataAMSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

AMSF has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AMSF's earnings are expected to decrease with -5.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.63%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.61%, AMSF has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.76, AMSF pays a bit more dividend than its industry peers.
AMSF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

The dividend of AMSF decreases each year by -0.15%.
AMSF has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.15%
Div Incr Years0
Div Non Decr Years0
AMSF Yearly Dividends per shareAMSF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

180.75% of the earnings are spent on dividend by AMSF. This is not a sustainable payout ratio.
AMSF's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP180.75%
EPS Next 2Y-5.63%
EPS Next 3YN/A
AMSF Yearly Income VS Free CF VS DividendAMSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMSF Dividend Payout.AMSF Dividend Payout, showing the Payout Ratio.AMSF Dividend Payout.PayoutRetained Earnings

AMERISAFE INC

NASDAQ:AMSF (7/14/2025, 8:22:49 PM)

After market: 44.82 0 (0%)

44.82

+0.66 (+1.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners101.2%
Inst Owner Change0%
Ins Owners1.28%
Ins Owner Change6.14%
Market Cap853.82M
Analysts76
Price Target57.46 (28.2%)
Short Float %0.82%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend4.47
Dividend Growth(5Y)-0.15%
DP180.75%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-13 2025-06-13 (0.39)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.68%
Min EPS beat(2)-3.53%
Max EPS beat(2)4.89%
EPS beat(4)1
Avg EPS beat(4)-2.58%
Min EPS beat(4)-9.06%
Max EPS beat(4)4.89%
EPS beat(8)2
Avg EPS beat(8)-3.21%
EPS beat(12)4
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)-1.34%
Revenue beat(2)0
Avg Revenue beat(2)-6.75%
Min Revenue beat(2)-7.3%
Max Revenue beat(2)-6.19%
Revenue beat(4)2
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-7.3%
Max Revenue beat(4)2.43%
Revenue beat(8)3
Avg Revenue beat(8)-1.88%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)7
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-2.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.45%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE 18.44
Fwd PE 19.97
P/S 2.85
P/FCF 57.71
P/OCF 57.33
P/B 3.27
P/tB 3.27
EV/EBITDA 13.52
EPS(TTM)2.43
EY5.42%
EPS(NY)2.24
Fwd EY5.01%
FCF(TTM)0.78
FCFY1.73%
OCF(TTM)0.78
OCFY1.74%
SpS15.73
BVpS13.69
TBVpS13.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.1%
ROE 18.2%
ROCE 5.19%
ROIC 4.17%
ROICexc 4.34%
ROICexgc 4.93%
OM 19.34%
PM (TTM) 15.84%
GM N/A
FCFM 4.94%
ROA(3y)4.74%
ROA(5y)4.96%
ROE(3y)20.1%
ROE(5y)19.3%
ROIC(3y)4.78%
ROIC(5y)4.81%
ROICexc(3y)4.99%
ROICexc(5y)5.03%
ROICexgc(3y)5.72%
ROICexgc(5y)5.69%
ROCE(3y)5.96%
ROCE(5y)5.99%
ROICexcg growth 3Y2.96%
ROICexcg growth 5Y-5.98%
ROICexc growth 3Y2.27%
ROICexc growth 5Y-6.79%
OM growth 3Y-3.47%
OM growth 5Y-8.09%
PM growth 3Y-5.13%
PM growth 5Y-6.1%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 9.81%
Cap/Sales 0.03%
Interest Coverage 250
Cash Conversion 25.27%
Profit Quality 31.18%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC9.07%
ROIC/WACC0.46
Cap/Depr(3y)92.38%
Cap/Depr(5y)99.43%
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.37%
Profit Quality(3y)45.41%
Profit Quality(5y)52.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.27%
EPS 3Y-3.68%
EPS 5Y-11.34%
EPS Q2Q%-13.04%
EPS Next Y-7.94%
EPS Next 2Y-5.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y-0.45%
Revenue growth 5Y-3.91%
Sales Q2Q%-9.81%
Revenue Next Year-1.6%
Revenue Next 2Y1.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.39%
EBIT growth 3Y-3.9%
EBIT growth 5Y-11.68%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.89%
FCF growth 3Y-13.99%
FCF growth 5Y-21.39%
OCF growth 1Y-56.96%
OCF growth 3Y-13.98%
OCF growth 5Y-21.04%